StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.76+0.00 (+0.07%)

Close on Nov 17, 2026Market cap $34.21MP/E –Yield –

TELA Bio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

TELA Bio's enterprise value was $67.88M on Nov 11, 2026, against $58.17M a year earlier. Over the last 5 years it ranged from $26.40M to $211.38M, with a median of $98.31M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$67.88M+14.3%
2025Dec 31, 2025$59.38M-39.6%
2024Dec 31, 2024$98.31M-31.9%
2023Dec 29, 2023$144.27M-29.9%
2022Dec 30, 2022$205.87M+56.0%
2021Dec 31, 2021$132.01M-2.6%
2020Dec 31, 2020$135.59M–
2019Dec 31, 2019-$13.45M–

More TELA Bio figures

See a number that looks wrong?